Categories
Bacil Pharma Ltd — Board Meeting, 22-05-2026: Board Meeting
22-05-2026 · 08:44 pm
BACIL PHARMA LIMITED's board approved audited financial results for Q4 & FY26. For the year, revenue was ₹1.23 Cr. The company reported a net loss of ₹0.61 Cr for the period. Auditors provided an unmodified opinion on the financials.
No comments yet. Be the first to comment!